Next Article in Journal
Overview on Biological Activities and Molecular Characteristics of Sulfated Polysaccharides from Marine Green Algae in Recent Years
Next Article in Special Issue
Effect of Salicornia herbacea on Osteoblastogenesis and Adipogenesis in Vitro
Previous Article in Journal
Bioactive Compounds from Macroalgae in the New Millennium: Implications for Neurodegenerative Diseases
Previous Article in Special Issue
Production of Avaroferrin and Putrebactin by Heterologous Expression of a Deep-Sea Metagenomic DNA
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 12
Issue 9
10.3390/md12094973
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Additional Evidence of the Trypanocidal Action of (−)-Elatol on Amastigote Forms through the Involvement of Reactive Oxygen Species

by
Vânia Cristina Desoti
1,
Danielle Lazarin-Bidóia
1,
Daniela Bueno Sudatti
2,
Renato Crespo Pereira
2,
Tania Ueda-Nakamura
1,3,
Celso Vataru Nakamura
1,3 and
Sueli De Oliveira Silva
1,3,*
1
Postgraduate Program in Pharmaceutical Sciences, State University of Maringa, Colombo Avenue 5790, Maringa, Parana CEP 87020-900, Brazil
2
Department of Marine Biology, Federal Fluminense University, P.O. Box 100644, Niteroi, Rio de Janeiro CEP 24001-970, Brazil
3
Department of Basic Health Sciences, State University of Maringa, Colombo Avenue 5790, Maringa, Parana CEP 87020-900, Brazil
*
Author to whom correspondence should be addressed.
Mar. Drugs 2014, 12(9), 4973-4983; https://doi.org/10.3390/md12094973
Submission received: 24 January 2014 / Revised: 25 March 2014 / Accepted: 23 April 2014 / Published: 25 September 2014
(This article belongs to the Special Issue Advances and New Perspectives in Marine Biotechnology)
Browse Figures
Versions Notes

Abstract

:
Chagas’ disease, a vector-transmitted infectious disease, is caused by the protozoa parasite Trypanosoma cruzi. Drugs that are currently available for the treatment of this disease are unsatisfactory, making the search for new chemotherapeutic agents a priority. We recently described the trypanocidal action of (−)-elatol, extracted from the macroalga Laurencia dendroidea. However, nothing has been described about the mechanism of action of this compound on amastigotes that are involved in the chronic phase of Chagas’ disease. The goal of the present study was to evaluate the effect of (−)-elatol on the formation of superoxide anions (O2•−), DNA fragmentation, and autophagy in amastigotes of T. cruzi to elucidate the possible mechanism of the trypanocidal action of (−)-elatol. Treatment of the amastigotes with (−)-elatol increased the formation of O2•− at all concentrations of (−)-elatol assayed compared with untreated parasites. Increased fluorescence was observed in parasites treated with (−)-elatol, indicating DNA fragmentation and the formation of autophagic compartments. The results suggest that the trypanocidal action of (−)-elatol might involve the induction of the autophagic and apoptotic death pathways triggered by an imbalance of the parasite’s redox metabolism.

1. Introduction

Chagas’ disease is a vector-transmitted infectious disease that is caused by the protozoa parasite Trypanosoma cruzi. It affects approximately 10 million individuals in worldwide [1]. This disease is appearing in non-endemic areas, because of immigration, through non-vectorial transmission mechanisms, such as congenital, blood transfusion and organs donation [2]. In turn, it is appearing in endemic countries mainly through of foodborne transmission, which have attracted great attention [3]. The available therapies for this infection are based on two nitroheterocyclics, nifurtimox and benznidazole, that are unsatisfactory because they present low efficacy, with cure rates of 60% in the acute phase and only 10%–20% in the chronic phase of the disease [4]. Additionally, serious toxic side effects are associated with nifurtimox and benznidazole [4,5] with prolonged treatment [6]. Thus, the search for new chemotherapeutic agents is a priority.
Numerous compounds have been studied for the treatment of Chagas’ disease [7]. For example, the literature presents studies of extracts and pure compounds obtained from marine algae with trypanocidal activity [8,9,10], but little is known about the biochemical alterations induced by them. We recently described the trypanocidal mechanism of action of (−)-elatol, a halogenated sesquiterpene extracted from the red macroalga Laurencia dendroidea (Figure 1), collected on the Brazilian coast, on trypomastigote forms of T. cruzi [11]. However, nothing has been described about the mechanism of action of this compound on amastigote forms that are involved in the chronic phase of Chagas’ disease. Both forms, trypomastigotes (nonreplicative) and amastigotes (replicative), are infective forms found in the vertebrate host [12].
Marinedrugs 12 04973 g001 1024
Figure 1. Chemical structure of (−)-elatol (A), the halogenated sesquiterpene extracted from the red macroalga Laurencia dendroidea (B).
Figure 1. Chemical structure of (−)-elatol (A), the halogenated sesquiterpene extracted from the red macroalga Laurencia dendroidea (B).
Marinedrugs 12 04973 g001
Considering the trypanocidal activity of (−)-elatol and lack of information on the mechanism of action in amastigote forms of T. cruzi, the present study provides data on the probable mode of trypanocidal action. Based on the ultrastructural alterations observed in intracellular amastigotes treated with (−)-elatol [10] and autophagic compartments and DNA fragmentation observed herein, we conclude that amastigotes treated with (−)-elatol died through autophagic and apoptotic processes. Our results provide further insights into the mechanism of action of (−)-elatol, strongly suggesting that (−)-elatol may be an effective treatment for Chagas’ disease with remarkable trypanocidal action against the amastigote forms of T. cruzi.

2. Results and Discussion

Natural products have proven to be valuable sources of new therapeutic agents that act against infectious and noninfectious diseases by providing an alternative to conventional treatments [7]. However, few studies of marine natural products have been conducted, despite the fact that marine algae have been used in traditional remedies in many Asian countries [13]. These natural products hold great promise. For example, bioactive compounds [14,15,16], such as the halogenated sesquiterpene (−)-elatol from Laurencia dendroidea, have significant biological activities. Some studies have demonstrated the chemotherapeutic properties of this compound, including antibacterial [17,18,19] and antiprotozoal activity [10,20], especially in the amastigote forms of T. cruzi [10]. Therefore, we sought to delineate the putative mechanism of action of (−)-elatol in amastigote forms.
Based on our previous results obtained with trypomastigotes treated with (−)-elatol [11], we evaluated the production of superoxide anions (O2•−), a reactive species of oxygen (ROS). The production of this radical was measured using a highly sensitive fluorimetric assay in mitochondria of the amastigote forms of T. cruzi treated with (−)-elatol. As shown in Figure 2, (−)-elatol significantly increased O2•− production at all concentrations of (−)-elatol tested over 3 h compared with untreated cells. A 60% increase was observed in higher concentration compared with the negative control. The positive control with antimicyn A also increased mitochondrial O2•− production (data not shown).
Marinedrugs 12 04973 g002 1024
Figure 2. Mitochondrial O2•− production in amastigote forms of Trypanosoma cruzi treated with 3, 15, and 30 μM (−)-elatol for up to 3 h using the fluorescent probe MitoSOX. At the indicated times, amastigotes were used to fluorimetrically measure oxidized MitoSOX (oxMitoSOX). The results are expressed in arbitrary units (mean ± SD of at least three independent experiments). * p ≤ 0.05, significant differences relative to the negative control (untreated cells; two-way analysis of variance followed by Tukey post hoc test).
Figure 2. Mitochondrial O2•− production in amastigote forms of Trypanosoma cruzi treated with 3, 15, and 30 μM (−)-elatol for up to 3 h using the fluorescent probe MitoSOX. At the indicated times, amastigotes were used to fluorimetrically measure oxidized MitoSOX (oxMitoSOX). The results are expressed in arbitrary units (mean ± SD of at least three independent experiments). * p ≤ 0.05, significant differences relative to the negative control (untreated cells; two-way analysis of variance followed by Tukey post hoc test).
Marinedrugs 12 04973 g002
The increase in O2•− production, induced by (−)-elatol, might induce radical reactions triggering a cascade of damage, such as a break in DNA that is a hallmark of apoptotic death [21]. The apoptotic process is associated with signaling cascades involving mitochondria (intrinsic pathway) or death receptors (extrinsic pathway) [22]. In both pathways ROS can act as signaling molecules [23]. As shown in Figure 3, bright fluorescence, indicating DNA fragmentation, was observed in amastigote forms treated with 1.5 and 3 μM (−)-elatol for 24 h and subjected to the TUNEL assay (Figure 3D,F, respectively). The untreated control was TUNEL-negative (Figure 3B). Additionally, bright fluorescence was observed with actinomycin D, a known inducer of apoptosis (data not shown).
Marinedrugs 12 04973 g003 1024
Figure 3. DNA fragmentation in amastigote forms of Trypanosoma cruzi treated with (−)-elatol for 24 h using TUNEL assay. The gray column is differential interference contrast (DIC), and the black column is fluorescence. Untreated amastigote forms (A and B). Amastigote forms treated with 1.5 μM (−)-elatol (C and D). Amastigote forms treated with 3 μM (−)-elatol (E and F). Scale bar = 10 μM.
Figure 3. DNA fragmentation in amastigote forms of Trypanosoma cruzi treated with (−)-elatol for 24 h using TUNEL assay. The gray column is differential interference contrast (DIC), and the black column is fluorescence. Untreated amastigote forms (A and B). Amastigote forms treated with 1.5 μM (−)-elatol (C and D). Amastigote forms treated with 3 μM (−)-elatol (E and F). Scale bar = 10 μM.
Marinedrugs 12 04973 g003
Based on our previous work that showed extensive vacuolization in the amastigote and trypomastigote forms of T. cruzi treated with (−)-elatol, demonstrated by transmission electron microscopy and fluorescence microscopy, respectively [10,11], we assessed whether autophagy is an alternative pathway to cell death induced by (−)-elatol in amastigote forms. Autophagy is a mechanism that involves degradation of unnecessary or dysfunctional cellular molecules through the actions of lysosomes/vacuole [24]. The cellular damage might be result from the high levels of ROS that can oxidize macromolecules [25]. Thus, we evaluated autophagy in amastigotes treated with (−)-elatol and stained with monodansylcadaverine, a fluorescent marker that accumulates in autophagic vacuoles [26]. Figure 4 shows the presence of fluorescent, rounded structures in cells treated with (−)-elatol, indicating the formation of autophagic compartments (Figure 4D,F), in contrast to untreated cells (Figure 4B). This effect could be partially prevented in amastigotes that were pretreated with wortmannin (Figure 4H).
Marinedrugs 12 04973 g004 1024
Figure 4. Autophagic compartments in amastigote forms of Trypanosoma cruzi treated with (−)-elatol for 24 h and stained with monodansylcadaverine. The gray column is differential interference contrast (DIC), and the black column is fluorescence. Untreated amastigote forms (A and B). Amastigote forms treated with 1.5 μM (−)-elatol (C and D). Amastigote forms treated with 3 μM (−)-elatol (E and F). Amastigote forms treated with 3 μM (−)-elatol + 500 nM wortmannin (G and H). Scale bar = 10 μM.
Figure 4. Autophagic compartments in amastigote forms of Trypanosoma cruzi treated with (−)-elatol for 24 h and stained with monodansylcadaverine. The gray column is differential interference contrast (DIC), and the black column is fluorescence. Untreated amastigote forms (A and B). Amastigote forms treated with 1.5 μM (−)-elatol (C and D). Amastigote forms treated with 3 μM (−)-elatol (E and F). Amastigote forms treated with 3 μM (−)-elatol + 500 nM wortmannin (G and H). Scale bar = 10 μM.
Marinedrugs 12 04973 g004
The results presented above indicate that (−)-elatol induces alterations that might be responsible for two types of cell death, apoptosis (demonstrated by DNA fragmentation; type I programmed cell death [PCD]) [27,28] and autophagy (demonstrated by the formation of autophagic vacuoles; type II PCD) [28], in amastigote forms of T. cruzi. Apoptosis has several classic characteristics, such as DNA fragmentation, which is one of the final steps in the apoptotic process [21,23]. Autophagy is characterized by an increase in cytoplasmic vacuolization [29,30]. Both cell death pathways have been well described for trypanosomatids, with significant mitochondrion and ROS participation [31,32]. However, independent of the pathway, (−)-elatol affected mitochondrial function by increasing mitochondrial O2•− production. Reactive oxygen species might trigger biochemical alterations that lead to cell death. Interestingly, the evidence suggests that the transition from apoptosis or autophagy is associated with excessive mitochondrial ROS production [33,34].

3. Experimental Section

3.1. Chemicals and Materials

Actinomycin D, antimycin A, dimethylsulfoxide, monodansylcadaverine, and wortmannin were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco’s modified Eagle’s medium (DMEM) and fetal bovine serum (FBS) were obtained from Invitrogen (Grand Island, NY, USA). The MitoSOX and TUNEL kits were obtained from Invitrogen (Eugene, OR, USA). All of the other reagents were analytical-grade.

3.2. Isolation of (−)-Elatol from L. dendroidea

The halogenated sesquiterpene (−)-elatol was isolated from specimens of the red macroalga L. dendroidea collected by hand during low tide in the midlittoral zone on the rocky coast of Cabo Frio Island (22°59′ S, 42°59′ W), Rio de Janeiro State, Brazil. The seaweed was transported to the laboratory between moist paper sheets inside individual plastic bags that were placed in coolers. These specimens were dried in the dark at room temperature to avoid photolysis and thermal degradation. Dr. Mutue Toyota Fujii identified the specimens of L. dendroidea used in this study, and voucher specimens were deposited in the herbaria SP, Instituto de Botânica, São Paulo State, Brazil (SP no. 399789).
The freeze-dried algal material (300 g) yielded 50 mg (−)-elatol through successive and exhaustively extraction in n-hexane at room temperature for 15 days. The solvent was eliminated in a rotary evaporator at low temperature (<50 °C), yielding 3.64 g of a dark green extract that contained the sesquiterpene (−)-elatol, which was detected as a blue spot on TLC plates after spraying with a solution of ceric sulfate and sulfuric acid (2.1 g Ce2[SO4]3·4H2O, 21 mL H2SO4, and 300 mL H2O), followed by heating at 100 °C for 3 min. An aliquot of the extract (0.35 g) was subjected to preparative thin-layer chromatography (PTLC; Merck; silica gel 60 F254, 20 × 20 cm, mobile phase: n-hexane:ethyl acetate [8:2]), to yield a yellowish oil (50 mg) that was identified as the sesquiterpene (−)-elatol. The purity was confirmed by TLC (Rf = 0.45) using n-hexane:AcOEt (8:2) as the mobile phase and 1H-NMR spectroscopy (300 MHz), and comparisons were made with the literature [35].
(−)-Elatol stock solutions (1 mg/mL) were prepared in dimethylsulfoxide (DMSO). All of the groups (including controls) were tested at final concentrations of less than 1% DMSO, which has no effect on amastigotes (data not shown). The concentrations of (−)-elatol used in the assays were equal to and above 50% inhibitory concentration (IC50) value [10].

3.3. Parasites and Cells

All of the experiments were performed using the Y strain of T. cruzi. Amastigote forms were obtained from the supernatants of previously infected monolayers of LLCMK2 cells (epithelial cells of monkey kidney [Macaca mulatta]; CCL-7; American Type Culture Collection, Rockville, MD, USA) in DMEM supplemented with 2 mM L-glutamine, 10% FBS, and 50 mg/L gentamicin and buffered with sodium bicarbonate in a 5% CO2 air mixture at 37 °C.

3.4. Fluorimetric Detection of Mitochondrion-Derived O2•−

The mitochondrial production of O2•− was evaluated during exposure of the amastigotes to 3, 15 and 30 μM of (−)-elatol using the fluorescent O2•−-sensitive, mitochondrial-targeted probe MitoSOX (3,8-phenanthridinediamine,5-[6-triphenylphosphoniumhexyl]-5,6-dihydro-6-phenyl). Amastigotes (2 × 107 cells/mL) were preloaded with 5 μM MitoSOX for 10 min at room temperature and then washed with Krebs-Henseleit buffer (pH 7.3) that contained 15 mM NaHCO3, 5 mM KCl, 120 mM NaCl, 0.7 mM Na2HPO4, and 1.5 mM NaH2PO4 before the assays. Loaded cells were exposed to different concentrations of (–)-elatol. After different times (0–3 h), fluorescence was measured in a fluorescence microplate reader (Victor X3, PerkinElmer) at λex = 510 nm and λem = 580 nm. Oxidized MitoSOX becomes highly fluorescent upon binding to nucleic acids. In some of the experiments, the cells were exposed to 10 μM antimycin A, which is known to induce mitochondrial O2•− production [36].

3.5. Evaluation of DNA Fragmentation

DNA fragmentation was evaluated in situ using terminal deoxynucleotide transferase dUTP nick-end labeling (TUNEL). Amastigote forms (1 × 107 cells/mL) were treated with 1.5 and 3 μM (−)-elatol for 24 h at 37 °C after the cells were subjected to the TUNEL assay according to the manufacturer’s instructions. The compound actinomycin D (20 mM) was used as a positive control. Cells that undergo DNA double-strand ruptures should fluoresce brightly, unlike untreated cells. Fluorescence was observed in a fluorescence microscope Olympus BX51 (Olympus®, Tokyo, Japan) at λex = 495 nm and λem = 519 nm, and images were captured with a UC30 camera (Olympus®).

3.6. Evaluation of Autophagic Compartments

Autophagic compartments were evaluated using monodansylcadaverine labeling [37]. Amastigote forms (1 × 107 cells/mL) were treated with 1.5 and 3 μM (−)-elatol for 24 h at 37 °C. The cells were then incubated with 0.05 mM monodansylcadaverine in phosphate-buffered saline (PBS) for 15 min at 37 °C. After incubation, the cells were washed in PBS two times. Monodansylcadaverine staining was analyzed using a fluorescence microscope Olympus BX51 (Olympus®) at λex = 380 nm and λem = 525 nm, and images were captured with a UC30 camera (Olympus®). In some of the experiments, the cells were pretreated with 500 nM wortmannin before the induction of autophagy. The compound is a potent phosphatidylinositol 3-kinase (PI3K) inhibitor, an enzyme that is involved in autophagy regulation [38].

3.7. Statistical Analysis

The data shown in the graphs are expressed as the mean ± standard deviation of at least three independent experiments. The data were analyzed using two-way analysis of variance (ANOVA), and significant differences among means were identified using the Tukey post hoc test. Values of p ≤ 0.05 were considered statistically significant. The statistical analyses were performed using Statistica software.

4. Conclusions

In summary, the present study provided further insights into the effects of (–)-elatol on amastigote forms of T. cruzi in an attempt to find new and specific therapies for Chagas’ disease. (–)-Elatol might be an effective compound for further in vivo analysis and may be a prototypical compound for the development of synthetic derivatives that may be used to treat this infection that affects millions of people in Latin America.

Acknowledgments

This work was supported by grants from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Capacitação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Financiadora de Estudos e Projetos (FINEP), Programa de Núcleos de Excelência (PRONEX/Fundação Araucária), Programa de Pós-Graduação em Ciências Farmacêuticas da Universidade Estadual de Maringá, Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM), and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ).

Author Contributions

Conceived and designed the experiments: V.C.D., D.L.-B., D.B.S, R.C.P and S.O.S. Performed the experiments: V.C.D., D.L.-B. and D.B.S. Analyzed the data: V.C.D., D.L.-B., D.B.S, R.C.P., C.V.N. and S.O.S. Contributed reagents/materials/analysis tools: R.C.P., T.U.-N., C.V.N and S.O.S. Collected the macroalga: D.B.S and R.C.P. Wrote the paper: V.C.D., D.L.-B., D.B.S, R.C.P., C.V.N. and S.O.S.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. World Health Organization (WHO). First WHO Report on Neglected Tropical Diseases: Working to Overcome the Global Impact of Neglected Tropical Diseases; WHO: Geneva, Switzerland, 2010. Available online: http://whqlibdoc.who.int/publications/2010/9789241564090_eng.pdf (accessed on 10 December 2013).
  2. Rassi, A., Jr.; Rassi, A.; Marin-Neto, J.A. Chagas’ disease. Lancet 2010, 375, 1388–1402. [Google Scholar] [CrossRef] [PubMed]
  3. Pereira, K.S.; Schmidt, F.L.; Guaraldo, A.M.A.; Franco, R.M.B.; Dias, V.L.; Passos, L.A.C. Chagas’ disease as a foodborne illness. J. Food Prot. 2009, 72, 441–446. [Google Scholar] [PubMed]
  4. Coura, J.R.; Castro, S.L. A critical review on Chagas’ disease chemotherapy. Mem. Inst. Oswaldo Cruz 2002, 97, 3–24. [Google Scholar] [CrossRef] [PubMed]
  5. Coura, J.R. Present situation and new strategies for Chagas’ disease chemotherapy: A proposal. Mem. Inst. Oswaldo Cruz 2009, 104, 549–554. [Google Scholar] [PubMed]
  6. Izumi, E.; Morello, L.G.; Ueda-Nakamura, T.U.; Yamada-Ogatta, S.F.; Dias Filho, B.P.; Cortez, D.A.G.; Ferreira, I.C.P.; Morgado-Díaz, J.A.; Nakamura, C.V. Trypanosoma cruzi: Antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms. Exp. Parasitol. 2008, 118, 324–330. [Google Scholar]
  7. Izumi, E.; Ueda-Nakamura, T.; Dias Filho, B.P.; Veiga-Júnior, V.F.; Nakamura, C.V. Natural products and Chagas’ disease: A review of plant compounds studied for activity against Trypanosoma cruzi. Nat. Prod. Rep. 2011, 28, 809–823. [Google Scholar]
  8. Nara, T.; Kamei, Y.; Tsubouchi, A.; Annoura, T.; Hirota, K.; Iizumi, K.; Dohmoto, Y.; Ono, T.; Aoki, T. Inhibitory action of marine algae extracts on the Trypanosoma cruzi dihydroorotate dehydrogenase activity and on the protozoan growth in mammalian cells. Parasitol. Int. 2005, 54, 59–64. [Google Scholar] [CrossRef] [PubMed]
  9. Spavieri, J.; Allmendinger, A.; Kaiser, M.; Casey, R.; Hingley-Wilson, S.; Lalvani, A.; Guiry, M.D.; Blunden, G.; Tasdemir, D. Antimycobacterial, antiprotozoal and cytotoxic potential of twenty-one brown algae (Phaeophyceae) from British and Irish waters. Phytother. Res. 2010, 24, 1724–1729. [Google Scholar] [CrossRef] [PubMed]
  10. Veiga-Santos, P.; Pelizzaro-Rocha, K.J.; Santos, A.O.; Ueda-Nakamura, T.; Dias Filho, B.P.; Silva, S.O.; Sudatti, D.B.; Bianco, E.M.; Pereira, R.C.; Nakamura, C.V. In vitro antitrypanosomal activity of elatol isolated from red seaweed Laurencia dendroidea. Parasitology 2010, 137, 1661–1670. [Google Scholar] [CrossRef] [PubMed]
  11. Desoti, V.C.; Lazarin-Bidóia, D.; Sudatti, D.B.; Pereira, R.C.; Alonso, A.; Ueda-Nakamura, T.; Dias Filho, B.P.; Nakamura, C.V.; Silva, S.O. Trypanocidal action of (−)-elatol involves an oxidative stress triggered by mitochondria dysfunction. Mar. Drugs 2012, 10, 1631–1646. [Google Scholar] [CrossRef] [PubMed]
  12. De Souza, W.; de Carvalho, T.M.; Barrias, E.S. Review on Trypanosoma cruzi: Host cell interaction. Int. J. Cell Biol. 2010, 2010, 1–18. [Google Scholar]
  13. Wang, B.-G.; Zhang, W.-W.; Duan, X.-J.; Li, X.-M. In vitro antioxidative activities of extract and semi-purified fractions of the marine red alga, Rhodomela confervoides (Rhodomelaceae). Food Chem. 2009, 113, 1101–1105. [Google Scholar] [CrossRef]
  14. Chatter, R.; Othman, R.B.; Rabhi, S.; Kladi, M.; Tarhouni, S.; Vagias, C.; Roussis, V.; Guizani-Tabbane, L.; Kharrat, R. In vivo and in vitro anti-inflammatory activity of neorogioltriol, a new diterpene extracted from the red algae Laurencia glandulifera. Mar. Drugs 2011, 9, 1293–1306. [Google Scholar] [CrossRef] [PubMed]
  15. Pacheco, F.C.; Villa-Pulgarin, J.A.; Mollinedo, F.; Martín, M.N.; Fernández, J.J.; Daranas, A.H. New polyether triterpenoids from Laurencia viridis and their biological evaluation. Mar. Drugs 2011, 9, 2220–2235. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Liang, Y.; Li, X.-M.; Cui, C.-M.; Li, C.-S.; Sun, H.; Wang, B.-G. Sesquiterpene and acetogenin derivatives from the marine red alga Laurencia okamurai. Mar. Drugs 2012, 10, 2817–2825. [Google Scholar] [CrossRef] [PubMed]
  17. Vairappan, C.S.; Daitoh, M.; Suzuki, M.; Abe, T.; Masuda, M. Antibacterial halogenated metabolites from the Malaysian Laurencia species. Phytochemistry 2001, 58, 291–297. [Google Scholar] [CrossRef] [PubMed]
  18. Vairappan, C.S. Potent antibacterial activity of halogenated metabolites from Malaysian red algae, Laurencia majuscule (Rhodomelaceae, Ceramiales). Biomol. Eng. 2003, 20, 255–259. [Google Scholar] [CrossRef] [PubMed]
  19. Paradas, W.C.; Salgado, L.T.; Sudatti, D.B.; Crapez, M.A.; Fujii, M.T.; Coutinho, R.; Pereira, R.C.; Amado Filho, G.M. Induction of halogenated vesicle transport in cells of the red seaweed Laurencia obtusa. Biofouling 2010, 26, 277–286. [Google Scholar] [CrossRef] [PubMed]
  20. Santos, A.O.; Veiga-Santos, P.; Ueda-Nakamura, T.; Dias Filho, B.P.; Sudatti, D.B.; Bianco, E.M.; Pereira, R.C.; Nakamura, C.V. Effect of elatol, isolated from red seaweed Laurencia dendroidea on Leishmania amazonensis. Mar. Drugs 2010, 8, 2733–2743. [Google Scholar] [CrossRef] [PubMed]
  21. Kroemer, G.; Galluzzi, L.; Vandenabeele, P.; Abrams, J.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; El-Deiry, W.S.; Golstein, P.; Green, D.R.; et al. Classification of cell death recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16, 3–11. [Google Scholar] [CrossRef] [PubMed]
  22. Igney, F.H.; Krammer, P.H. Death and anti-death: Tumour resistance to apoptosis. Nat. Rev. Cancer 2002, 2, 277–288. [Google Scholar] [CrossRef] [PubMed]
  23. Mignotte, B.; Vayssiere, J.-L. Mitochondria and apoptosis. Eur. J. Biochem. 1998, 252, 1–15. [Google Scholar] [CrossRef] [PubMed]
  24. Klionsky, D.J.; Emr, S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290, 1717–1721. [Google Scholar] [CrossRef] [PubMed]
  25. Ba, X.; Gupta, S.; Davidson, M.; Garg, N.J. Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes. J. Biol. Chem. 2010, 285, 11596–11606. [Google Scholar] [CrossRef] [PubMed]
  26. Biederbick, A.; Kern, H.F.; Elsasser, H.P. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur. J. Cell Biol. 1995, 66, 3–14. [Google Scholar] [PubMed]
  27. Samuilov, V.D.; Oleskin, A.V.; Lagunova, E.M. Programmed cell death. Biochemistry Mosc. 2000, 65, 873–887. [Google Scholar] [PubMed]
  28. Kanzawa, T.; Kondo, Y.; Ito, H.; Kondo, S.; Germano, I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 2003, 63, 2103–2108. [Google Scholar] [PubMed]
  29. Tsujimoto, Y.; Shimizu, S. Another way to die: Autophagic programmed cell death. Cell Death Differ. 2005, 12, 1528–1534. [Google Scholar] [CrossRef] [PubMed]
  30. Jiménez-Ruiz, A.; Alzate, J.F.; MacLeod, E.T.; Lüder, C.G.; Fasel, N.; Hurd, H. Apoptotic markers in protozoan parasites. Parasit. Vectors 2010, 3, 1–15. [Google Scholar] [CrossRef] [PubMed]
  31. Menna-Barreto, R.F.S.; Salomão, K.; Dantas, A.P.; Santa-Rita, R.M.; Soares, M.J.; Barbosa, H.S.; de Castro, S.L. Different cell death pathways induced by drugs in Trypanosoma cruzi: An ultrastructural study. Micron 2009, 40, 157–168. [Google Scholar] [CrossRef] [PubMed]
  32. Smirlis, D.; Duszenko, M.; Jiménez-Ruiz, A.; Scoulica, E.; Bastien, P.; Fasel, N.; Soteriadou, K. Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death. Parasit. Vectors 2010, 3, 1–15. [Google Scholar] [CrossRef] [PubMed]
  33. Addabbo, F.; Montagnani, M.; Goligorsky, M.S. Mitochondria and reactive oxygen species. Hypertension 2009, 53, 885–892. [Google Scholar] [CrossRef] [PubMed]
  34. Kaminskyy, V.O.; Zhivotovsky, B. Free radicals in cross talk between autophagy and apoptosis. Antioxid. Redox Signal. 2014, in press. [Google Scholar]
  35. Konig, G.M.; Wright, A.D. Sesquiterpene content of the antibacterial dichlormethane extract of the red alga Laurencia obtusa. Planta Med. 1997, 63, 186–187. [Google Scholar] [CrossRef] [PubMed]
  36. Piacenza, L.; Irigoin, F.; Alvarez, M.N.; Peluffo, G.; Taylor, M.C.; Kelly, J.M.; Wilkinson, S.R.; Radi, R. Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: Cytoprotective action of mitochondrial iron superoxide dismutase overexpression. Biochem. J. 2007, 403, 323–334. [Google Scholar] [CrossRef] [PubMed]
  37. Munafó, D.B.; Colombo, M.I. A novel assay to study autophagy: Regulation of autophagosome vacuole size by amino acid deprivation. J. Cell Sci. 2001, 114, 3619–3629. [Google Scholar] [PubMed]
  38. Wymann, M.P.; Bulgarelli-Leva, G.; Zvelebil, M.J.; Pirola, L.; Vanhaesebroeck, B.; Waterfield, M.D.; Panayotou, G. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol. Cell Biol. 1996, 16, 1722–1733. [Google Scholar]

Share and Cite

MDPI and ACS Style

Desoti, V.C.; Lazarin-Bidóia, D.; Sudatti, D.B.; Pereira, R.C.; Ueda-Nakamura, T.; Nakamura, C.V.; De Oliveira Silva, S. Additional Evidence of the Trypanocidal Action of (−)-Elatol on Amastigote Forms through the Involvement of Reactive Oxygen Species. Mar. Drugs 2014, 12, 4973-4983. https://doi.org/10.3390/md12094973

AMA Style

Desoti VC, Lazarin-Bidóia D, Sudatti DB, Pereira RC, Ueda-Nakamura T, Nakamura CV, De Oliveira Silva S. Additional Evidence of the Trypanocidal Action of (−)-Elatol on Amastigote Forms through the Involvement of Reactive Oxygen Species. Marine Drugs. 2014; 12(9):4973-4983. https://doi.org/10.3390/md12094973

Chicago/Turabian Style

Desoti, Vânia Cristina, Danielle Lazarin-Bidóia, Daniela Bueno Sudatti, Renato Crespo Pereira, Tania Ueda-Nakamura, Celso Vataru Nakamura, and Sueli De Oliveira Silva. 2014. "Additional Evidence of the Trypanocidal Action of (−)-Elatol on Amastigote Forms through the Involvement of Reactive Oxygen Species" Marine Drugs 12, no. 9: 4973-4983. https://doi.org/10.3390/md12094973

APA Style

Desoti, V. C., Lazarin-Bidóia, D., Sudatti, D. B., Pereira, R. C., Ueda-Nakamura, T., Nakamura, C. V., & De Oliveira Silva, S. (2014). Additional Evidence of the Trypanocidal Action of (−)-Elatol on Amastigote Forms through the Involvement of Reactive Oxygen Species. Marine Drugs, 12(9), 4973-4983. https://doi.org/10.3390/md12094973

Article Metrics

Back to TopTop